Actionable news
0
All posts from Actionable news
Actionable news in TEVA: TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES,

Teva now expecting to have generic EpiPen out by 2018

Facing delays after its marketing application was rejected this year, Teva Pharmaceutical (TEVA -1.7%) now says it wants to get U.S. approval for a generic version of Mylan's (MYL -1.7%) EpiPen by late 2017 or early 2018.

"We requested a meeting with the FDA," and didn't get a response, said Teva's...


More